Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cesca Therapeutics I (KOOL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 35,739
  • Shares Outstanding, K 9,900
  • Annual Sales, $ 11,930 K
  • Annual Income, $ -18,590 K
  • 36-Month Beta -0.72
  • Price/Sales 1.85
  • Price/Cash Flow N/A
  • Price/Book 1.15

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +20.33%
on 06/23/17
3.85 -6.23%
on 07/10/17
+0.58 (+19.14%)
since 06/20/17
3-Month
2.84 +27.11%
on 05/12/17
3.85 -6.23%
on 07/10/17
+0.49 (+15.71%)
since 04/20/17
52-Week
2.41 +49.79%
on 12/21/16
7.39 -51.15%
on 08/03/16
+0.47 (+14.97%)
since 07/20/16

Most Recent Stories

More News
Company News for July 11, 2017

Companies in the News are: HCOM,CBB,KOOL,MYCC,APO,CETV

APO : 27.87 (+0.61%)
CBB : 18.15 (+0.83%)
KOOL : 3.61 (-2.43%)
HCOM : 29.03 (+0.94%)
MYCC : 16.95 (unch)
CETV : 4.20 (+1.20%)
Cesca Therapeutics Acquires the Cell Processing Systems of SynGen Under Asset Acquisition Agreement

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that its wholly-owned subsidiary, ThermoGenesis Corp.,...

KOOL : 3.61 (-2.43%)
Cesca Therapeutics Set to Join Russell Microcap(R) Index

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, is set to join the Russell Microcap(R) Index at the conclusion of...

KOOL : 3.61 (-2.43%)
Stem Cells Market 2016-2024 - Global Strategic Business Report 2017

Research and Markets has announced the addition of the "Stem Cells - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada,...

CUR : 5.35 (-1.11%)
KOOL : 3.61 (-2.43%)
CYTX : 1.12 (+1.82%)
OSIR : 6.8400 (+0.59%)
LZAGF : 225.4600 (+1.33%)
MESO : 7.75 (+1.04%)
RNUGF : 0.0320 (+44.14%)
TIG : 21.02 (-0.38%)
ISCO : 1.3300 (-1.48%)
OMED : 3.63 (-0.55%)
ATHX : 1.63 (unch)
Cesca Therapeutics to Present at the Inaugural Cell and Gene Exchange 2017

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Dr. Dalip Sethi, senior director of research...

KOOL : 3.61 (-2.43%)
Cesca Therapeutics Announces Fiscal Third Quarter and Nine Month 2017 Financial and Operating Results and Provides Corporate Update

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced financial and operating results for the fiscal third...

KOOL : 3.61 (-2.43%)
Investor Network: Cesca Therapeutics Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 11, 2017 / Cesca Therapeutics Inc. (NASDAQ: KOOL) will be discussing their earnings results in their Q3 Earnings Call to be held May 11, 2017 at 4:30 PM Eastern Time.

KOOL : 3.61 (-2.43%)
Cesca Therapeutics to Announce Fiscal Third Quarter 2017 Financial Results on May 11, 2017

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the company will report its financial results...

KOOL : 3.61 (-2.43%)
Cesca to Exhibit at the 25th International Society for Cellular Therapy (ISCT) Annual Meeting

Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that ThermoGenesis, the company's device subsidiary,...

KOOL : 3.61 (-2.43%)
CESCA Therapeutics to Present at the 2017 International Symposium of Translational Medicine in Stem Cell Myocardial Repair

Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Dr. Xiaochun (Chris) Xu, Chairman and Interim...

KOOL : 3.61 (-2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation,...

See More

Support & Resistance

2nd Resistance Point 3.68
1st Resistance Point 3.64
Last Price 3.61
1st Support Level 3.59
2nd Support Level 3.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.